Company Filing History:
Years Active: 2012-2013
Title: Innovations of Cheolju Lee: A Pioneer in Calcium Channel Modulators and Alpha-1-Antitrypsin Muteins.
Introduction
Cheolju Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of novel compounds that serve as calcium channel modulators and improvements in protein stability.
Latest Patents
Cheolju Lee holds two recent patents that showcase his innovative work. The first patent involves imidazolylalkylcarbonyl derivatives, which are identified as useful calcium channel modulators. This patent also includes a preparation method for these compounds, which can be utilized in treating diseases by leveraging their inhibitory activity against calcium channels. The second patent focuses on a thermostable alpha-1-antitrypsin mutein that features a disulfide bond. This invention enhances the thermostability of the alpha-1-antitrypsin mutein while maintaining its activity, making it suitable for use as a protein-based therapeutic agent and in various applications, including diagnostic reagents.
Career Highlights
Cheolju Lee is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development activities. His work has led to advancements in therapeutic agents that are stable in vivo, contributing to the broader field of medical science.
Collaborations
Some of his notable coworkers include Kyung Il Choi and Ghilsoo Nam, who have collaborated with him on various projects, enhancing the impact of their research.
Conclusion
Cheolju Lee's innovative contributions to the field of biochemistry, particularly through his patents on calcium channel modulators and alpha-1-antitrypsin muteins, highlight his role as a significant inventor in the scientific community. His work continues to pave the way for advancements in therapeutic applications.